Vera Therapeutics (VERA) Retained Earnings (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Retained Earnings data on file, last reported at -$156000.0 in Q1 2026.

• Quarterly Retained Earnings rose 99.97% year-over-year to -$156000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$156000.0 (up 99.97% YoY) and the FY2025 annual result came in at $786000.0, up 100.17% from the prior year.
• Retained Earnings retreated to -$156000.0 in Q1 2026, from $786000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $786000.0 in Q4 2025 to a low of -$669.8 million in Q3 2025.
• A 5-year average of -$154.2 million and a median of -$279000.0 in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings tumbled 557000.0% — and 2025, when it jumped 217.11%.
• Tracing VERA's Retained Earnings over 5 years: stood at -$224000.0 in 2022, then soared by 212.05% to $251000.0 in 2023, then sank by 183864.94% to -$461.2 million in 2024, then soared by 100.17% to $786000.0 in 2025, then sank by 119.85% to -$156000.0 in 2026.
• The last three Retained Earnings figures came in at -$156000.0 (Q1 2026), $786000.0 (Q4 2025), and -$669.8 million (Q3 2025), per Business Quant data.